Brought to you by Pizza Hut
Tue, 21 Feb 2012 09:00:00 EST (New York, NY, February, 21, 2012) The Rottenstein Law Group, which represents clients with claims stemming from the surgical implantation of hip replacement devices manufactured and sold by DePuy Orthopaedics and other companies, notes that a doctor-consultant for the troublesome DePuy ASR systems has evidently disavowed the use of metal-on-metal hip implants.
At the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons held in San Francisco from February 7 to 11, at a panel presentation entitled 'Metal-on-Metal Hip Replacement: Current Status and Recommendations for Patient Management,' panellist Dr. Thomas Schmalzried, long known to be one of the developers of the controversial ASR hip replacement systems, conceded that all-metal hip replacements should not be used.
Dr. Schmalzried, the Medical Director of the Joint Replacement Institute at St. Vincent Medical Center in Los Angeles, stated that he has received royalties from DePuy, a division of Johnson & Johnson, as well as research funds from DePuy, Wright Medical, Corin, Piedmont Foundation and St. Vincent Medical Center. When asked by panel moderator Dr. William Maloney how he intended to replace cobalt and/or chromium hip replacement elements in future revision surgeries, Dr. Schmalzried replied, 'I'm going to be using more ceramic with a titanium taper sleeve.' When Dr. Maloney pointed out that 'There is no indication of for a metal-on-metal total hip replacement,' Dr. Schmalzried agreed, as did every other member on the panel, as seen in the video of the panel presentation.
In August, 2010, the U.S. Food and Drug Administration (FDA) requested a recall of DePuy's ASR hip replacement systems, due to an unacceptably high rate of failure. The devices were failing an estimated 12% within five years of initial implantation. The FDA based its approval of the ASR devices on their similarity to the Pinnacle systems, which were already for sale, and in widespread use. Currently, the FDA is receiving complaints about the older Pinnacle systems; to date, there have been more than 1,300 reports citing that the device loosens and causes severe pain when the recipient engages in simple movements and normal, everyday activities. Another serious side effect of the Pinnacle systems was reported by the New York Times in December, claiming that metal can flake off the device and embed itself into the surrounding tissue, putting the recipient at risk of developing metal poisoning. At least one plaintiff has already filed a lawsuit claiming this very issue with his Pinnacle hip replacement system.
The Rottenstein Law Group is advising anyone with a friend or relative who has undergone a hip replacement procedure to reach out to that person and recommend that he or she consult a physician immediately and then speak to a qualified personal injury lawyer. The Rottenstein Law Group lawyers have a total of more than 25 years of experience fighting for the rights of clients who have suffered harm due to the negligence of powerful corporations. Affected individuals can also stay apprised of the latest developments in the DePuy Pinnacle situation by visiting the DePuy Hip Replacement Recall Information Center. The site is equipped with easy-to-use social media features which will enable users to spread the word about DePuy Pinnacle hip replacement device failures.
About the Rottenstein Law Group
The Rottenstein Law Group is a New York-based law firm that represents clients in mass tort actions. The firm was founded by Rochelle Rottenstein, a lawyer with over two decades of experience in compassionate representation of clients in consumer product injury, mass tort, and class action law suits. For more information, please visit their Web site, or call (888) 9-ROT-LAW.
(New York, NY, February, 21, 2012) The Rottenstein Law Group, which represents clients with claims stemming from the surgical implantation of hip replacement devices manufactured and sold by DePuy Orthopaedics and other companies, notes that a doctor-consultant for the troublesome DePuy ASR systems has evidently disavowed the use of metal-on-metal hip implants.